Medicus Pharma Ltd. (MDCX)
Data as of , from SEC Form 4 filings.
See up to 3 months of MDCX. The 7-day demo opens the 1M and 3M ranges and puts MDCX on your watchlist.
Start 7-day demoLatest MDCX insider trades
About Medicus Pharma Ltd. (MDCX)
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
- W. CONSHOHOCKEN, PA
- 16
- 2023
- Nasdaq
MDCX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 10 | 8,430,881 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MDCX insider transactions (Form 4)
3543 Form 4 filings on record, the earliest from Jul 22, 2025, newest first. Filing history page 1 of 2.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Andrew Alasdair Smith - Officer | Grant or award | Common Shares, no par value | 735,294 | $8.53 | $125K | |
| Andrew Alasdair Smith - Officer | Grant or award | Stock Option (right to buy) | 125,000 | $0.00 | - | |
| Faisal Mehmud - Officer | Grant or award | Common Shares, no par value | 1,470,588 | $8.53 | $251K | |
| Faisal Mehmud - Officer | Grant or award | Stock Option (right to buy) | 250,000 | $0.00 | - | |
| Edward J. Brennan - Officer | Grant or award | Common Shares, no par value | 588,235 | $8.53 | $100K | |
| Edward J. Brennan - Officer | Grant or award | Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Carolyn F. Bonner - Officer | Grant or award | Common Shares, no par value | 1,470,588 | $8.53 | $251K | |
| Carolyn F. Bonner - Officer | Grant or award | Stock Option (right to buy) | 250,000 | $0.00 | - | |
| Raza Bokhari - Officer | Grant or award | Common Shares, no par value | 2,941,176 | $8.53 | $501K | |
| Raza Bokhari - Officer | Grant or award | Stock Option (right to buy) | 500,000 | $0.00 | - | |
| Andrew Alasdair Smith - Officer | Grant or award | Stock Option (right to buy) | 200,000 | $0.00 | - | |
 Cathy McMorris Rodgers - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Ajay Raju - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Faisal Mehmud - Officer | Grant or award | Stock Option (right to buy) | 250,000 | $0.00 | - | |
| Sara R. May - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Patrick J. Mahaffy - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Larry Kaiser - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Barry Fishman - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Robert J. Ciaruffoli - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Edward J. Brennan - Officer | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Carolyn F. Bonner - Officer | Grant or award | Stock Option (right to buy) | 250,000 | $0.00 | - | |
| Raza Bokhari - Officer | Grant or award | Stock Option (right to buy) | 500,000 | $0.00 | - | |
| William Ashton - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Andrew Alasdair Smith - Officer | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Cathy McMorris Rodgers - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Ajay Raju - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Faisal Mehmud - Officer | Grant or award | Stock Option (right to buy) | 125,000 | $0.00 | - | |
| Sara R. May - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Patrick J. Mahaffy - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Larry Kaiser - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Barry Fishman - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Robert J. Ciaruffoli - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Edward J. Brennan - Officer | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Carolyn F. Bonner - Officer | Grant or award | Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Raza Bokhari - Officer | Grant or award | Stock Option (right to buy) | 325,000 | $0.00 | - |
MDCX insider trading FAQ
What is the latest insider trade for MDCX?
Medicus Pharma Ltd. (MDCX) had 5 insider filings in the last 90 days, with the most recent on 8 September 2026. The full record for MDCX runs to 43 Form 4 filings, the earliest from 22 July 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MDCX stock?
No insider purchases of MDCX were filed in the last 90 days.
How many insiders are selling MDCX stock?
No insider sales of MDCX were filed in the last 90 days.
Where can I see MDCX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MDCX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Andrew Alasdair Smith view on EDGAR
- - Faisal Mehmud view on EDGAR
- - Edward J. Brennan view on EDGAR
- - Carolyn F. Bonner view on EDGAR
- - Raza Bokhari view on EDGAR
- - Andrew Alasdair Smith view on EDGAR
- - Cathy McMorris Rodgers view on EDGAR
- - Ajay Raju view on EDGAR
- - Faisal Mehmud view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where MDCX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MDCX with a 7-day demo
- MDCX on your watchlist
- Every MDCX Form 4 filing on record
- Up to 3 months of MDCX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
